Zevra Therapeutics Inc (ZVRA) USD0.0001
2.61%- This stock can be held in a
Stocks and Shares ISASell:$8.30
Buy:$8.31
Change:
$0.35
(4.41%)
$0.35
(4.41%)Market closed | Prices delayed by at least 15 minutes
Sell:$8.30
Buy:$8.31
Change:$0.35
(4.41%)
$0.35
(4.41%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 30,544 | $8.05 | $245,961.67 | 191,516 |
| 13 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 61,273 | $7.86 | $481,428.09 | 222,060 |
| 13 February 2025 | R Laduane CliftonCFO | Sell Option/Award related | 11,000 | $7.86 | $86,471.00 | 51,361 |
| 13 February 2025 | Joshua M (Josh) SchaferChief Level Officer | Sell Option/Award related | 10,500 | $7.86 | $82,526.85 | 29,486 |
| 13 February 2025 | Timothy J SangiovanniController/Treasurer | Sell Option/Award related | 3,000 | $7.86 | $23,587.80 | 16,341 |
| 11 October 2024 | Corey Michael WattonIndependent Director | Buy Regular purchase transaction | 500 | $7.92 | $3,957.65 | 1,500 |
| 17 July 2024 | R Laduane CliftonCFO | Buy Regular purchase transaction | 2,000 | $6.77 | $13,540.00 | 18,469 |
| 16 July 2024 | Thomas D (Tom) AndersonDirector | Buy Regular purchase transaction | 10,000 | $6.81 | $68,065.00 | 20,000 |
| 12 July 2024 | John B BodeDirector | Buy Regular purchase transaction | 10,000 | $5.87 | $58,661.00 | 30,000 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 13 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 61,273 | $7.86 | $481,428.09 | 222,060 |
| 14 February 2025 | Neil F McFarlanePresident/CEO | Sell Option/Award related | 30,544 | $8.05 | $245,961.67 | 191,516 |
| 13 February 2025 | R Laduane CliftonCFO | Sell Option/Award related | 11,000 | $7.86 | $86,471.00 | 51,361 |
| 13 February 2025 | Joshua M (Josh) SchaferChief Level Officer | Sell Option/Award related | 10,500 | $7.86 | $82,526.85 | 29,486 |
| 16 July 2024 | Thomas D (Tom) AndersonDirector | Buy Regular purchase transaction | 10,000 | $6.81 | $68,065.00 | 20,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.